Weiselberg L - Search Results

1

Phase II study of 4-demethoxydaunorubicin in advanced ovarian carcinoma.

Hakes TB, Daghestani AN, Dougherty JB, Weiselberg L, Raymond V. Hakes TB, et al. Among authors: weiselberg l. Cancer Treat Rep. 1985 May;69(5):559-60. Cancer Treat Rep. 1985. PMID: 3859369 No abstract available.

2

Phase II trial of spirogermanium in advanced epithelial carcinoma of the ovary.

Weiselberg L, Budman DR, Schulman P, Vinciguerra V, Degnan TJ, Pasmantier M. Weiselberg L, et al. Cancer Treat Rep. 1982 Aug;66(8):1675-6. Cancer Treat Rep. 1982. PMID: 7201885 No abstract available.

3

Phase I trial of vinzolidine.

Budman DR, Schulman P, Marks M, Vinciguerra V, Weiselberg L, Kreis W, Degnan TJ. Budman DR, et al. Among authors: weiselberg l. Cancer Treat Rep. 1984 Jul-Aug;68(7-8):979-82. Cancer Treat Rep. 1984. PMID: 6744350

4

Phase II trial of mitomycin, vinblastine, and cisplatin (MVP) in non-small cell bronchogenic carcinoma.

Schulman P, Budman DR, Weiselberg L, Vinciguerra V, Degnan TJ. Schulman P, et al. Among authors: weiselberg l. Cancer Treat Rep. 1983 Oct;67(10):943-5. Cancer Treat Rep. 1983. PMID: 6684988

5

Phase II study of divided-dose vinblastine in non-small cell bronchogenic carcinoma.

Schulman P, Budman DR, Vinciguerra V, Weiselberg L, Abrams S, Degnan T. Schulman P, et al. Among authors: weiselberg l. Cancer Treat Rep. 1982 Jan;66(1):171-2. Cancer Treat Rep. 1982. PMID: 7053253

6

Pharmacokinetic and phase I evaluation of esorubicin (4'-deoxydoxorubicin) by continuous infusion over forty-eight hours in patients with leukemia.

Kreis W, Rottach C, Budman DR, Chan K, Schulman P, Allen SL, Weiselberg L, Vinciguerra V. Kreis W, et al. Among authors: weiselberg l. Cancer Res. 1988 Oct 1;48(19):5580-4. Cancer Res. 1988. PMID: 3166400

7

Use of cisplatin for elderly patients.

Lichtman SM, Buchholtz M, Marino J, Schulman P, Allen SL, Weiselberg L, Budman D, DeMarco L, Schuster M, Lovecchio J, et al. Lichtman SM, et al. Among authors: weiselberg l. Age Ageing. 1992 May;21(3):202-4. doi: 10.1093/ageing/21.3.202. Age Ageing. 1992. PMID: 1615783

8

Tamoxifen in unresectable hypernephroma. A phase II trial and review of the literature.

Weiselberg L, Budman D, Vinciguerra V, Schulman P, Degnan TJ. Weiselberg L, et al. Cancer Clin Trials. 1981;4(2):195-8. Cancer Clin Trials. 1981. PMID: 7249256

9

Therapy of refractory/relapsed acute leukemia with cytosine arabinoside plus tetrahydrouridine (an inhibitor of cytidine deaminase)--a pilot study.

Kreis W, Budman DR, Chan K, Allen SL, Schulman P, Lichtman S, Weiselberg L, Schuster M, Freeman J, Akerman S, et al. Kreis W, et al. Among authors: weiselberg l. Leukemia. 1991 Nov;5(11):991-8. Leukemia. 1991. PMID: 1961042 Clinical Trial.

10

Phase I trial of intravenous vinzolidine (LY 104208) given on a biweekly dosing schedule.

Budman DR, Kreis W, Behr J, Schulman P, Lichtman S, Allen SL, Weiselberg L, Satterlee WG, Nelson RL, Vinciguerra V. Budman DR, et al. Among authors: weiselberg l. Invest New Drugs. 1990 Aug;8(3):269-74. doi: 10.1007/BF00171836. Invest New Drugs. 1990. PMID: 2272767 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters